ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00254280
Recruitment Status : Unknown
Verified May 2008 by Bispebjerg Hospital.
Recruitment status was:  Active, not recruiting
First Posted : November 16, 2005
Last Update Posted : June 2, 2008
Sponsor:
Information provided by:
Bispebjerg Hospital

Brief Summary:
The purpose of the study is for recalcitrant hand and foot warts to compare the efficacy of treatment with Intense Pulsed Light and paring versus paring alone.

Condition or disease Intervention/treatment Phase
Warts Procedure: Intense Pulsed Light + paring versus paring alone Not Applicable

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Official Title: Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light and Paring Versus Paring Alone - a Randomized Controlled Trial With Blinded Response Evaluation
Study Start Date : November 2005
Study Completion Date : September 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Foot Health Warts
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years or older
  • Recalcitrant warts
  • No previous IPL treatment of warts

Exclusion Criteria:

  • Immunosuppressive treatment
  • Patients suffering from HIV, diabetes or other immunosuppressive diseases
  • Pregnancy
  • Previous IPL treatment
  • Patients with a tendency to prodyce keloids or hypertrophic scars
  • Mosaic and flat warts
  • Lack of informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00254280


Locations
Denmark
Bispebjerg hospital
Copenhagen, Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Principal Investigator: Merete Haedersdal, MD, PhD, DrMedSci Bispebjerg Hospital

ClinicalTrials.gov Identifier: NCT00254280     History of Changes
Other Study ID Numbers: KF-01-255566
First Posted: November 16, 2005    Key Record Dates
Last Update Posted: June 2, 2008
Last Verified: May 2008

Keywords provided by Bispebjerg Hospital:
Warts
Intense pulsed light
RCT
Recalcitrant hand and foot warts

Additional relevant MeSH terms:
Warts
Papillomavirus Infections
DNA Virus Infections
Virus Diseases
Skin Diseases, Viral
Tumor Virus Infections
Skin Diseases, Infectious
Skin Diseases